RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer

E. Ratner, F. Keane, H. Yu, D. Zelterman, T. Rutherford, A. Santin, P. Schwartz, F. Slack, D. Levine, J. Weidhaas

Open source

DOI
10.1016/j.ygyno.2010.12.010
Published
2011-03
Container
Gynecologic Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2010.12.010,
  title = {RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer},
  author = {E. Ratner and F. Keane and H. Yu and D. Zelterman and T. Rutherford and A. Santin and P. Schwartz and F. Slack and D. Levine and J. Weidhaas},
  year = {2011},
  journal = {Gynecologic Oncology},
  doi = {10.1016/j.ygyno.2010.12.010},
  url = {https://doi.org/10.1016/j.ygyno.2010.12.010}
}

RIS

TY  - JOUR
TI  - RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer
AU  - E. Ratner
AU  - F. Keane
AU  - H. Yu
AU  - D. Zelterman
AU  - T. Rutherford
AU  - A. Santin
AU  - P. Schwartz
AU  - F. Slack
AU  - D. Levine
AU  - J. Weidhaas
PY  - 2011
JO  - Gynecologic Oncology
DO  - 10.1016/j.ygyno.2010.12.010
UR  - https://doi.org/10.1016/j.ygyno.2010.12.010
ER  - 

APA

Ratner, E., Keane, F., Yu, H., Zelterman, D., Rutherford, T., Santin, A., Schwartz, P., Slack, F., Levine, D., & Weidhaas, J. (2011). RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2010.12.010

Source records